| Analysis of the androgen receptor–regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression Y Zhang, S Pitchiaya, M Cieślik, YS Niknafs, JCY Tien, Y Hosono, MK Iyer, ... Nature genetics 50 (6), 814-824, 2018 | 203 | 2018 |
| Progression-free survival and patterns of response in patients with relapsed high-risk neuroblastoma treated with irinotecan/temozolomide/dinutuximab/granulocyte-macrophage … BJ Lerman, Y Li, C Carlowicz, M Granger, T Cash, A Sadanand, K Somers, ... Journal of Clinical Oncology 41 (3), 508-516, 2023 | 19 | 2023 |
| Exclusion criteria used in early behavioral intervention studies for young children with autism spectrum disorder S Yazdani, A Capuano, M Ghaziuddin, C Colombi Brain sciences 10 (2), 99, 2020 | 14 | 2020 |
| Characterizing the therapeutic potential of a potent BET degrader in merkel cell carcinoma JE Choi, ME Verhaegen, S Yazdani, R Malik, PW Harms, D Mangelberger, ... Neoplasia 21 (3), 322-330, 2019 | 6 | 2019 |
| Avoidant restrictive food intake disorder emerging during COVID-19 pandemic resulting in superior mesenteric artery syndrome S Yazdani, Z Bloomberg, R Klauber, E Meresh Eating and Weight Disorders-Studies on Anorexia, Bulimia and Obesity 27 (7 …, 2022 | 2 | 2022 |
| Progression-free survival and patterns of response in patients with high-risk neuroblastoma (HR-NB) treated with irinotecan/temozolomide/dinutuximab/granulocyte-macrophage … B Lerman, Y Li, M Granger, T Cash, A Sadanand, K Somers, A Ranavaya, ... Journal of Clinical Oncology 40 (16_suppl), 10025-10025, 2022 | 1 | 2022 |
| Integrative analysis of androgen receptor regulated long non-coding RNA in prostate cancer R Malik, Y Zhang, M Cieslik, YS Niknafs, S Pitchiaya, Y Hosono, ... Cancer Research 76 (14_Supplement), 983-983, 2016 | 1 | 2016 |
| Corrigendum to “Characterizing the Therapeutic Potential of a Potent BET Degrader in Merkel Cell Carcinoma”[Neoplasia, Volume 21, Issue 3 (2019) 322–330] JE Choi, ME Verhaegen, S Yazdani, R Malik, PW Harms, D Mangelberger, ... Neoplasia (New York, NY) 51, 2024 | | 2024 |
| PIKfyve controls dendritic cell function and tumor immunity JE Choi, Y Qiao, I Kryczek, J Yu, J Gurkan, Y Bao, M Gondal, JCY Tien, ... bioRxiv, 2024.02. 28.582543, 2024 | | 2024 |
